#1 Clinical Trials Search in Europe

Promazine Hydrochloride

This article discusses clinical trials investigating the use of Promazine Hydrochloride in the treatment of schizophrenia and related disorders. Promazine Hydrochloride is an antipsychotic medication being studied alongside other treatments to evaluate its effectiveness in managing symptoms and improving cognitive function in patients with schizophrenia spectrum disorders. The trials aim to compare different treatment approaches and assess their impact on various aspects of the condition.

Table of Contents

What is Promazine Hydrochloride?

Promazine Hydrochloride is a medication that belongs to a class of drugs called phenothiazines. It is primarily used as an antipsychotic medication to treat various mental health conditions[1]. Promazine Hydrochloride is also known by its brand name, which may vary depending on the country and manufacturer.

Medical Conditions Treated

Promazine Hydrochloride is used to treat several mental health conditions, including:

  • Schizophrenia: A severe mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior[1].
  • Schizoaffective disorder: A condition that combines symptoms of schizophrenia and mood disorders[1].
  • Schizophreniform disorder: A short-term type of schizophrenia that lasts between one and six months[1].

It’s important to note that Promazine Hydrochloride may also be used for other conditions not listed here, as determined by your healthcare provider.

How Promazine Hydrochloride Works

Promazine Hydrochloride works by altering the balance of certain chemicals in the brain, particularly dopamine. By blocking dopamine receptors, it helps to reduce the intensity of psychotic symptoms such as hallucinations, delusions, and disorganized thinking[1].

Dosage and Administration

The dosage of Promazine Hydrochloride can vary depending on the individual patient and the condition being treated. Based on the clinical trial information, the maximum daily dose is typically 400 mg, with a maximum total dose of 16,800 mg over a 6-week treatment period[1]. However, it’s crucial to follow your doctor’s prescription exactly, as they will determine the appropriate dosage for your specific situation.

Promazine Hydrochloride is usually taken orally, meaning by mouth[1]. Your doctor will provide specific instructions on how and when to take the medication.

Potential Side Effects

Like all medications, Promazine Hydrochloride can cause side effects. Some common side effects may include:

  • Drowsiness
  • Dry mouth
  • Blurred vision
  • Constipation
  • Weight gain

More serious side effects can occur, although they are less common. These may include movement disorders, changes in heart rhythm, or severe allergic reactions. It’s important to report any unusual symptoms to your healthcare provider promptly[1].

Precautions and Contraindications

Promazine Hydrochloride may not be suitable for everyone. It’s important to inform your doctor about any other medications you’re taking, as well as any medical conditions you have. Particular caution is needed in the following situations:

  • Pregnancy or breastfeeding
  • History of heart problems
  • Liver or kidney disease
  • History of seizures
  • Glaucoma

Your doctor will consider these factors when deciding if Promazine Hydrochloride is appropriate for you[1].

Current Research and Clinical Trials

While the provided clinical trial information doesn’t specifically focus on Promazine Hydrochloride, it does mention research into treatments for schizophrenia and related disorders. One study is investigating the effects of early intensified pharmacological treatment compared to treatment as usual in patients who have experienced a first-time treatment failure[1].

Another study is looking at the cognitive effects of adding vortioxetine (an antidepressant) to the treatment of early schizophrenia[2]. While these studies don’t directly involve Promazine Hydrochloride, they demonstrate ongoing research efforts to improve treatments for schizophrenia and related disorders.

It’s important to stay informed about new developments in the treatment of your condition. However, always consult with your healthcare provider before making any changes to your treatment plan.

Aspect Details
Drug Studied Promazine Hydrochloride
Conditions Schizophrenia, Schizoaffective disorder, Schizophreniform disorder
Main Objectives Compare treatment effectiveness, assess symptom changes, evaluate cognitive improvements
Key Outcome Measures PANSS scores, CGI scores, cognitive function tests, quality of life assessments
Participant Age Range 18-70 years old
Trial Duration Varies, ranging from 6 weeks to 50 weeks
Comparison Groups Early intensified pharmacological treatment vs. Treatment as usual
Safety Assessments Monitoring of side effects, adverse events, and overall tolerability

FAQ

  • What is Promazine Hydrochloride? Promazine Hydrochloride is an antipsychotic medication being studied in clinical trials for the treatment of schizophrenia and related disorders. It belongs to a class of drugs known as phenothiazines.
  • What are the main objectives of the clinical trials involving Promazine Hydrochloride? The main objectives include comparing the effectiveness of different treatment approaches, assessing changes in symptom severity, evaluating improvements in cognitive function, and measuring changes in quality of life and overall functioning in patients with schizophrenia spectrum disorders.
  • Who can participate in these clinical trials? Participants are typically adults aged 18-70 with a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder. Specific eligibility criteria may vary between trials, but generally include factors such as symptom severity, treatment history, and overall health status.
  • What are some of the outcomes being measured in these trials? The trials measure various outcomes, including changes in symptom severity using scales like PANSS (Positive and Negative Syndrome Scale), improvements in cognitive function, changes in quality of life, presence of side effects, and overall treatment response.
  • How long do these clinical trials typically last? The duration of the trials can vary, but many last for several weeks to months. For example, one trial mentioned a six-week treatment period, while another included assessments up to 50 weeks after the start of the trial.

Ongoing Clinical Trials on Promazine Hydrochloride

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

Glossary

  • Promazine Hydrochloride: An antipsychotic medication belonging to the phenothiazine class, used in the treatment of schizophrenia and related disorders.
  • Schizophrenia: A serious mental disorder characterized by distortions in thinking, perception, emotions, language, sense of self, and behavior.
  • PANSS (Positive and Negative Syndrome Scale): A medical scale used for measuring symptom severity of patients with schizophrenia, evaluating positive symptoms, negative symptoms, and general psychopathology.
  • Cognitive function: Mental processes involved in gaining knowledge and comprehension, including thinking, knowing, remembering, judging, and problem-solving.
  • Antipsychotic: A type of medication used to manage psychosis, including delusions, hallucinations, paranoia, or disordered thought, particularly in schizophrenia and bipolar disorder.
  • Schizoaffective disorder: A mental health condition that includes features of both schizophrenia and mood disorders.
  • Schizophreniform disorder: A brief psychotic disorder with symptoms similar to schizophrenia but lasting less than six months.
  • CGI (Clinical Global Impression Scale): A rating scale used to assess the overall severity of a patient's illness, change in condition, and treatment response.
  • Randomized controlled trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare the effects of interventions.
  • Symptomatic remission: A state in which a patient experiences a significant reduction in symptoms, often defined by specific criteria in clinical trials.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effect-of-clozapine-and-drug-combination-for-patients-with-schizophrenia-experiencing-first-line-treatment-failure/
  2. http://clinicaltrials.eu/trial/study-on-the-effects-of-vortioxetine-on-cognitive-function-in-patients-with-early-schizophrenia/